Baidu
map

菲出现第2名MERS确诊病人 未有病毒传开迹象

2015-07-08 佚名 中国新闻网

菲律宾当局证实境内出现了第二名中东呼吸综合征(MERS)确诊病人,也是当地在韩国爆发疫情之后的第一例。不过当局说,至今未有任何病毒传开来的迹象。菲律宾卫生部周一宣布,一名上个月从迪拜抵达马尼拉的外国男子感染了MERS病毒。当局不愿透露这个病人的国籍,不过有报道指他是来自中东。“目前没有理由感到恐慌,我们呼吁公众尊重这名病人的隐私。”菲律宾卫生部发言人昨天在记者会上说,这名36岁的外国人从沙特阿拉伯

菲律宾当局证实境内出现了第二名中东呼吸综合征(MERS)确诊病人,也是当地在韩国爆发疫情之后的第一例。不过当局说,至今未有任何病毒传开来的迹象。

菲律宾卫生部周一宣布,一名上个月从迪拜抵达马尼拉的外国男子感染了MERS病毒。当局不愿透露这个病人的国籍,不过有报道指他是来自中东。“目前没有理由感到恐慌,我们呼吁公众尊重这名病人的隐私。”

菲律宾卫生部发言人昨天在记者会上说,这名36岁的外国人从沙特阿拉伯途经迪拜飞到马尼拉。他2日出现咳嗽等流感症状后前往私人医院求医,4日被转往公立医院检查,确诊为MERS。他一直在医院接受治疗,病情正在好转。

上述发言人说,当局正在对曾与这名男子有过接触的人进行追踪联系,包括跟他搭乘同个班机的人。不过他说,当局目前没有发现任何传播情况。他还说,这名患者体内的病毒量较少,传播可能性不大,而且他在出现症状后开始减少外出,与外界接触较少。

菲律宾是在今年2月发现第一个MERS病例。当时一名在沙特阿拉伯工作的女护士,在回到菲律宾后确诊染上中东呼吸综合征,她过后康复。上述这名中东男子也到过沙特阿拉伯。

全球第一起MERS病例于2012年在沙特阿拉伯出现,此后大部分病例集中在中东地区,以沙特占大多数。

今年5月初,韩国出现了第一个病例并迅速扩大,成为中东地区以外病例最多的地区。

韩国自5月2日宣布确诊首个MERS病例以来,累计已有超过180人染病,33人死亡。泰国在6月中发现境内第一个病例,该名75岁阿曼商人在曼谷接受治疗后,已于上周康复出院。

据世界卫生组织,亚洲地区至今曾出现过MERS确诊病例的,还有马来西亚和中国大陆,各有一例。

韩国爆发较大疫情后,世界卫生组织至今接获全球通报的MERS确诊病例已经超过1300个,至少464人已死亡,其中大约1000个病例在沙特。

中东呼吸综合征冠状病毒引发的典型症状包括发热、咳嗽和气促等,检查常可发现肺炎、腹泻等胃肠道症状。重症病例可导致呼吸衰竭,一些病例会出现器官衰竭,尤其是肾衰竭和感染性休克。科学家尚未确定病毒的源头,但好些研究结果指源头可能是骆驼。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1878121, encodeId=b81e18e8121a0, content=<a href='/topic/show?id=c157696175' target=_blank style='color:#2F92EE;'>#ERS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6961, encryptionId=c157696175, topicName=ERS)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=仁心济世, createdTime=Sat Feb 06 07:31:00 CST 2016, time=2016-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=33042, encodeId=a518330427b, content=预防很关键, beContent=null, objectType=article, channel=null, level=null, likeNumber=157, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3e301634976, createdName=1dd90e57m73(暂无匿称), createdTime=Sat Jul 18 17:33:00 CST 2015, time=2015-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1338432, encodeId=14f31338432f8, content=<a href='/topic/show?id=767711566a9' target=_blank style='color:#2F92EE;'>#MERS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11566, encryptionId=767711566a9, topicName=MERS)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/71tKRib0PibveVjnEa7tPLMaCzoKicFlKSEOzRTGf4wNvDV54kJyNx1ott1D5Xp5gRu7IwUia77oN0YFdffvQMu6Ug/132, createdBy=9e302500146, createdName=ms49895894946433513521, createdTime=Fri Jul 10 00:31:00 CST 2015, time=2015-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=31793, encodeId=b1c531e9329, content=积极防治, beContent=null, objectType=article, channel=null, level=null, likeNumber=167, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=01621631568, createdName=飞翔9899, createdTime=Thu Jul 09 10:01:00 CST 2015, time=2015-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=31556, encodeId=68543155669, content=看看, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee0d1618732, createdName=huaxipanxing, createdTime=Wed Jul 08 12:08:00 CST 2015, time=2015-07-08, status=1, ipAttribution=)]
    2016-02-06 仁心济世
  2. [GetPortalCommentsPageByObjectIdResponse(id=1878121, encodeId=b81e18e8121a0, content=<a href='/topic/show?id=c157696175' target=_blank style='color:#2F92EE;'>#ERS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6961, encryptionId=c157696175, topicName=ERS)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=仁心济世, createdTime=Sat Feb 06 07:31:00 CST 2016, time=2016-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=33042, encodeId=a518330427b, content=预防很关键, beContent=null, objectType=article, channel=null, level=null, likeNumber=157, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3e301634976, createdName=1dd90e57m73(暂无匿称), createdTime=Sat Jul 18 17:33:00 CST 2015, time=2015-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1338432, encodeId=14f31338432f8, content=<a href='/topic/show?id=767711566a9' target=_blank style='color:#2F92EE;'>#MERS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11566, encryptionId=767711566a9, topicName=MERS)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/71tKRib0PibveVjnEa7tPLMaCzoKicFlKSEOzRTGf4wNvDV54kJyNx1ott1D5Xp5gRu7IwUia77oN0YFdffvQMu6Ug/132, createdBy=9e302500146, createdName=ms49895894946433513521, createdTime=Fri Jul 10 00:31:00 CST 2015, time=2015-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=31793, encodeId=b1c531e9329, content=积极防治, beContent=null, objectType=article, channel=null, level=null, likeNumber=167, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=01621631568, createdName=飞翔9899, createdTime=Thu Jul 09 10:01:00 CST 2015, time=2015-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=31556, encodeId=68543155669, content=看看, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee0d1618732, createdName=huaxipanxing, createdTime=Wed Jul 08 12:08:00 CST 2015, time=2015-07-08, status=1, ipAttribution=)]
    2015-07-18 1dd90e57m73(暂无匿称)

    预防很关键

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1878121, encodeId=b81e18e8121a0, content=<a href='/topic/show?id=c157696175' target=_blank style='color:#2F92EE;'>#ERS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6961, encryptionId=c157696175, topicName=ERS)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=仁心济世, createdTime=Sat Feb 06 07:31:00 CST 2016, time=2016-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=33042, encodeId=a518330427b, content=预防很关键, beContent=null, objectType=article, channel=null, level=null, likeNumber=157, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3e301634976, createdName=1dd90e57m73(暂无匿称), createdTime=Sat Jul 18 17:33:00 CST 2015, time=2015-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1338432, encodeId=14f31338432f8, content=<a href='/topic/show?id=767711566a9' target=_blank style='color:#2F92EE;'>#MERS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11566, encryptionId=767711566a9, topicName=MERS)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/71tKRib0PibveVjnEa7tPLMaCzoKicFlKSEOzRTGf4wNvDV54kJyNx1ott1D5Xp5gRu7IwUia77oN0YFdffvQMu6Ug/132, createdBy=9e302500146, createdName=ms49895894946433513521, createdTime=Fri Jul 10 00:31:00 CST 2015, time=2015-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=31793, encodeId=b1c531e9329, content=积极防治, beContent=null, objectType=article, channel=null, level=null, likeNumber=167, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=01621631568, createdName=飞翔9899, createdTime=Thu Jul 09 10:01:00 CST 2015, time=2015-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=31556, encodeId=68543155669, content=看看, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee0d1618732, createdName=huaxipanxing, createdTime=Wed Jul 08 12:08:00 CST 2015, time=2015-07-08, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1878121, encodeId=b81e18e8121a0, content=<a href='/topic/show?id=c157696175' target=_blank style='color:#2F92EE;'>#ERS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6961, encryptionId=c157696175, topicName=ERS)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=仁心济世, createdTime=Sat Feb 06 07:31:00 CST 2016, time=2016-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=33042, encodeId=a518330427b, content=预防很关键, beContent=null, objectType=article, channel=null, level=null, likeNumber=157, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3e301634976, createdName=1dd90e57m73(暂无匿称), createdTime=Sat Jul 18 17:33:00 CST 2015, time=2015-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1338432, encodeId=14f31338432f8, content=<a href='/topic/show?id=767711566a9' target=_blank style='color:#2F92EE;'>#MERS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11566, encryptionId=767711566a9, topicName=MERS)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/71tKRib0PibveVjnEa7tPLMaCzoKicFlKSEOzRTGf4wNvDV54kJyNx1ott1D5Xp5gRu7IwUia77oN0YFdffvQMu6Ug/132, createdBy=9e302500146, createdName=ms49895894946433513521, createdTime=Fri Jul 10 00:31:00 CST 2015, time=2015-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=31793, encodeId=b1c531e9329, content=积极防治, beContent=null, objectType=article, channel=null, level=null, likeNumber=167, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=01621631568, createdName=飞翔9899, createdTime=Thu Jul 09 10:01:00 CST 2015, time=2015-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=31556, encodeId=68543155669, content=看看, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee0d1618732, createdName=huaxipanxing, createdTime=Wed Jul 08 12:08:00 CST 2015, time=2015-07-08, status=1, ipAttribution=)]
    2015-07-09 飞翔9899

    积极防治

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1878121, encodeId=b81e18e8121a0, content=<a href='/topic/show?id=c157696175' target=_blank style='color:#2F92EE;'>#ERS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6961, encryptionId=c157696175, topicName=ERS)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=仁心济世, createdTime=Sat Feb 06 07:31:00 CST 2016, time=2016-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=33042, encodeId=a518330427b, content=预防很关键, beContent=null, objectType=article, channel=null, level=null, likeNumber=157, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3e301634976, createdName=1dd90e57m73(暂无匿称), createdTime=Sat Jul 18 17:33:00 CST 2015, time=2015-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1338432, encodeId=14f31338432f8, content=<a href='/topic/show?id=767711566a9' target=_blank style='color:#2F92EE;'>#MERS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11566, encryptionId=767711566a9, topicName=MERS)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/71tKRib0PibveVjnEa7tPLMaCzoKicFlKSEOzRTGf4wNvDV54kJyNx1ott1D5Xp5gRu7IwUia77oN0YFdffvQMu6Ug/132, createdBy=9e302500146, createdName=ms49895894946433513521, createdTime=Fri Jul 10 00:31:00 CST 2015, time=2015-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=31793, encodeId=b1c531e9329, content=积极防治, beContent=null, objectType=article, channel=null, level=null, likeNumber=167, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=01621631568, createdName=飞翔9899, createdTime=Thu Jul 09 10:01:00 CST 2015, time=2015-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=31556, encodeId=68543155669, content=看看, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee0d1618732, createdName=huaxipanxing, createdTime=Wed Jul 08 12:08:00 CST 2015, time=2015-07-08, status=1, ipAttribution=)]
    2015-07-08 huaxipanxing

    看看

    0

相关资讯

为什么会有这么多新传染病?

当你打开这篇文章的时候,MERS病毒正在韩国肆虐。截至6月23日,韩国MERS确诊患者175人,死亡27人。这种号称中东呼吸综合征的传染病,至今仍然无法找到有效治愈方法。MERS病毒的袭来,再次唤醒人们对于SARS病毒的记忆:恐慌、不安和无助。从肺结核到到SARS再到埃博拉病毒、MERS,人类的发展史也是一部病菌抗击时,然而每次当新的病毒来临时,我们依旧要问,新病毒从何而来?为什么在科技如此发

似曾相识的场景!韩国民众抢购泡菜防MERS

据韩媒11日报道,韩国中东呼吸综合征(MERS)疫情持续扩散,韩国民众的不安心理也持续增加。最近MERS疫情显示,容易染病并死亡的大部分都是年老体弱的老年人,因此如何提高自身免疫力成为韩国民众热衷的话题。最近不仅是各种个人卫生用品热销,各种提高免疫力的保健食品也备受推崇。韩国民众抢购泡菜防MERS最近韩国大型超市的生姜、红薯、鲑鱼、泡菜等有助于增强免疫力的食品深受消费者青睐,销售趋旺。根据易买得1

韩国连现MERS第四代感染者:三轮人际传染,传播力超预期

6月15日,韩国首尔市城东区工作人员对该区公共交通工具进行消毒据韩国保健福祉部当天通报,韩国新增的5例中东呼吸综合征(MERS)确诊患者中,又有3例属于“第四代感染者”。这显示出病毒传播能力超过预期,韩国防疫形势更加严峻。根据韩国保健福祉部当天公布的数据,当日新增2例死亡病例,使得韩国中东呼吸综合征死亡人数增至16人。确诊患者升至150人。正在接受治疗的120名患者中,有17人病情较为严重。令人忧

MERS:沙特患者影像(图)

(A)男,61岁,胸片显示双肺网格结节影,血管标志物增加,全心增大。          (A) Chest radiograph of a 61-year-old man, showing bilateral fine reticulonodular air-space opacities, increased vascular

韩国MERS死亡人数升至20人 将尝试“血浆疗法”

据外媒17日报道,韩国新增一例中东呼吸综合征(MERS)死亡病例,死亡人数升至20人。韩国官员称,将会开始尝试“血浆疗法”。  所谓血浆治疗法,就是以康复患者的血液制成血浆来对付同种病毒。此疗法曾经用于治疗埃博拉等多种传染疾病,并且被证明是有效的。  但是,从三年前发现第一例MERS感染病例以来,医学界从未广泛地使用血浆疗法,而且也没有其他的有效治疗方法。  韩国保健福祉部长官文亨杓说,医院方面已

致死率高达50%的超级病菌KPC现身澳大利亚,超过MERS

根据澳洲网17日报道,一种致死率高达50%的超级病菌已经在澳大利亚维多利亚州感染数十人。据悉,从去年开始,这种超级病菌已经在维州一家医院直接致2人死亡。 维州各医院升级防控措施 据报道,维多利亚州各大医院从即日起开始高度关注这种名为耐碳青霉烯类抗生素肺炎克雷伯菌(Klebsiella pneumoniae carbapenemase,KPC)的超级病菌。因为该超级病菌的一个新变

Baidu
map
Baidu
map
Baidu
map